EPS inhibitor treatment of Salmonella impacts evolution without selecting for resistance to biofilm inhibition

Abstract Virulence factors of pathogens, such as toxin production and biofilm formation, often exhibit a public character, providing benefits to nearby non-producers. Consequently, anti-virulence drugs targeting these public traits may not select for resistance, as resistant mutants that resume prod...

Full description

Bibliographic Details
Published in:npj Biofilms and Microbiomes
Main Authors: Mathieu Joos, Sybren Van Ginneken, Xabier Villanueva, Marie Dijkmans, Guglielmo A. Coppola, Camilo Andres Pérez-Romero, Thijs Vackier, Erik Van der Eycken, Kathleen Marchal, Bram Lories, Hans P. Steenackers
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Online Access:https://doi.org/10.1038/s41522-025-00693-y